AC: Effect of capillary pressure and plasma protein on development of pulmonary edema. Am J Physiol 213: 79 82, 1967 12. Praiher JW, Gaar KA Jr, Guyton AC: Direct continuous recording of plasma colloid osmotic pressure of whole blood. J Appl Physiol 24: 602-605, 1968 13. Guyton AC: Interstitial fluid pressure. II. Pressure-volume curves of interstitial space. Circ Res 16: 452-460, 1965 14. Haddy FJ, Molner Jl, Campbell RW: Effect of denervation and vasoactive agents on vascular pressures and weight of dog forelimb. Am J Physiol 201: 631-638, 1961 15. Guyton AC: A concept of negative interstitial fluid pressure based on pressure in implanted perforated capsules. Circ Res 12: 399-414, 1963 16. Diana JN, Laughlin MH: Effect of ischemia on capillary pressure and equivalent pore radius in capillaries of the isolated dog hindlimb. Circ The influence of barbiturate anesthesia on renal blood flow was assessed by .he xenon washout method in trained dogs with catheters chronically implanted in the renal artery. Anesthesia induced with either thiopental soaium or pentobarbital sodium resulted in a striking reduction in renal blood flow (4.1 ± 0 . 1 vs. 2.6 ± 0.2 ml/g per min; P < 0.001) without a change in arterial pressure. The reduction in blood flow was prevented by a high salt intake and partially reversed by agents which interrupt the renin-angiotensin system ( B P F 9 S ; l-Sar,8-Ala-angiotensin II; propranolol) but not by a-adrenergic blocking agents (phentolamine and ' phenoxybenzamine). Anesthesia blunted the renal vascular response to angiotensin II (P < 0.0005) whereas responsiveness to norepinephrine was increased (P < 0.05). We conclude that barbiturate anesthesia induces a major, angiotensin-mediated renal vascular response which must be considered in the interpretation of experiments performed under these conditions.
A MAJOR cardiovascular response including reduced renal blood flow is often induced by anesthesia in man 1 " 1 and in experimental animals. 5 " Although the mechanisms for these are poorly defined, anesthesia-induced activation of the renin-angiotensin system*' l 2 ' 1 4 is a possible cause, as the renal vasculature is especially sensitive to angiotensin I I i s . i6 H0Wever, there is considerable discrepancy between reports on the sensitivity of the renovascular bed to angiotensin. 18 " 22 In man, for example, studies performed without anesthesia demonstrated a threshold response to angiotensin infused into the renal artery at doses generally below 10 ng/min," and the renal vessels were 100-fold more sensitive to angiotensin than to norepinephrine. In anesthetized animals, on the other hand, a number of studies have revealed a requirement for much higher doses of angiotensin 7 ' " " " and it has been suggested that the renal vessels are more sensitive to norepinephrine than to angiotensin." These discrepant results may be due to the fact that anesthesia can blunt renal vascular responses to angiotensin II,'-'" and perhaps reflect the frequent association of activation of the renin-angiotensin system and a reduction in vascular responsiveness to angiotensin I I . " It therefore seemed important to assess the role of renin-angi-otensin system activation in the renal vascular response to anesthesia. We have performed such a study in dogs with catheters chronically implanted in the renal artery. Using this model, we assessed the effects of barbiturate anesthesia and of sodium intake on renal perfusion and responsiveness to vasoconstrictor agents and appropriate blocking drugs.
Methods

SURGICAL PREPARATION
Studies were performed on 25 healthy, mongrel dogs, weighing 21-35 kg and selected for gentleness. In experiments in which surgery was performed, or when the effects of anesthesia per se were to be studied, anesthesia was induced with an initial intravenous dose of sodium pentobarbital (30 mg/kg) and maintained with periodic additional doses of 3-5 mg/kg of the same agent, to prevent spontaneous movement. At the time of preparative surgery a period of at least 60 minutes was allowed after the completion of procedures before vascular studies were performed; a 30minute period was allowed between the last supplemental dose of anesthesia and the hemodynamic study. On days during which surgery was not performed, the hemodynamic studies were performed 30 minutes after induction of anesthesia.
Several days prior to the surgical procedure an aortogram was obtained to define the renal vascular anatomy. On the day of preparative surgery the renal pedicle was approached through a flank incision by retroperitoneal dissection. The artery was exposed and its lateral margin cleaned suffi-ciently to allow catheterization with a polyvinyl chloride catheter (outside diameter, 0.040 inches; inside diameter, 0.025 inches; length, 50-60 cm; dead space volume about 0.7 ml) with a tapered tip as described in detail by Rudolph et al. 23 To monitor arterial pressure and obtain blood samples, a second, large (o.d., 0.70; i.d., 0.40) polyvinyl chloride catheter was placed in the aorta below the renal artery via a femoral or lumbar artery. A similar catheter was placed in a femoral or lumbar vein. All catheters were exteriorized through a lateral incision in the flank. After completion of the surgical procedure the catheters were flushed with a heparin solution (10 mg/ml), sealed, and protected for chronic use in the pocket of a specially prepared jacket (A. Chatham, Inc., Los Angeles).
TECHNIQUES
Arterial pressure was recorded with a Statham P23DC transducer on a Grass polygraph. During anesthesia respiration was controlled by means of a cuffed endotracheal tube and a Harvard respiratory pump, and rectal temperature was monitored with a Yellow Springs rectal probe and maintained at 36-37°C.
Blood flow was measured in all dogs with radioxenon, as described in detail in earlier publications, 16 and in three dogs with tagged microspheres. 24 Xenon with a specific activity of 1-2 mCi/ml was used. Blood flow was measured by injecting 100-400 /id in a volume of 0.1-0.4 ml as a bolus into the kidney through the catheter, followed by a 0.7-ml flush. The washout of the radioactive gas was monitored externally by a scintillation probe with a thallium-activated sodium iodide crystal ( 2 x 2 inches) connected to a pulse height analyzer with a window setting of 70-100 keV, a digital rate meter and recorder (Baird-Atomic, Inc., Cambridge, Mass.). This system was linear to 800,000 counts/min in the range of 70-100 keV. The peak counts were generally in the range of 80,000-400,000 counts/min. "Background prior to the first blood flow determination on any study day ranged from 400 to 2,000 counts/min and rose progressively with serial determinations on any day to a maximum of 40,000. The ratio of the peak count to background ranged from 20 to 50. Two methods of curve analysis were used. Mean blood flow was determined from the initial slope. Compartmental flow rates and distribution were determined by graphical analysis according to the method of Thorburn et al., 26 modified so that a smoothed 3-minute value was used to approximate the two slowest flow components. To assess the fidelity of the graphical analysis the initial slope was also assessed by an unweighted least squares program in 28 curves (r = 0.99; P < 0.001). Flow rates were calculated from the slopes with correction of the partition coefficient for hematocrit.
After the initial surgery the dogs were trained to lie on their sides without movement for periods of up to 60 minutes. Within several weeks they remained recumbent without movement despite catheter manipulation and noise. During the training period blood flow determinations were performed several times weekly. During each period four blood flow determinations were obtained at 15-minute intervals, to assess stability. A characteristic pattern emerged, in that the dogs would lie still on the table after a brief experience, but frequently at first showed a striking moment-to-moment variability of perfusion. During the next several weeks blood flow stabilized in each dog at much more constant levels, as described under Results. This period is defined as "stable." The pharmacological and dietary studies were performed during the stable period in random sequence. Studies were generally separated by 3-4 days.
Of the dogs which survived surgery one was excluded because catheter placement clearly induced renal artery stenosis. Three died in the postsurgical period. Catheter closure or leakage prevented successful completion of all experiments in an additional four. Thus data are available for 14 dogs for a variable interval following surgery, including 10 which were studied into the stable interval. We performed additional acute studies to correlate measurements of flow by microspheres and xenon. Over a range of flow from 1.8 to 7.9 ml/g per min there was excellent correlation between mean blood flow measured with xenon (JC) and microspheres (y); n = 9; y = 0.85x + 40; r = 0.94; P < 0.001.
PROTOCOLS
For every dog, the training period involved the systematic assessment of blood flow variability during any 60-minute period. Other experimental maneuvers were not used. Then a series of pharmacological studies was performed in a random sequence at intervals of 3-4 days. We assessed the influence of barbiturate anesthesia on renal hemodynamics by infusing either pentobarbital or thiopental sodium through the venous catheter. To evaluate the influence of the anesthetic agents on renal vascular reactivity to angiotensin II and norepinephrine we measured responses to graded doses of either agent infused into the renal artery with the dogs awake or anesthetized. A similar approach was used to assess the role of activation of the sympathetic nervous system and renin-angiotensin system by use of the specific pharmacological antagonists; the a-adrenergic blocking agents phentolamine and phenoxybenzamine; the competitive antagonist to angiotensin II, l-Sar,8-Ala-angiotensin II; BPF 9 a , an agent which blocks the conversion of angiotensin I to II; and propranolol, an agent which blocks renin release. All drug doses were calculated as the base. Except in studies performed to assess the efficacy of the doses of antagonists, only a single agent was administered on any day and all studies were performed in both awake and anesthetized dogs.
The relationship between the dose of angiotensin II (Hypertensin, CIBA) infused intra-arterially (i.a.) into the renal artery and the resulting change in blood flow was determined by infusing log-dose increments ranging from 3 to 100 ng/min with a motor-driven syringe in a volume of 0.3-1.0 ml/min. The agent was infused for 3 minutes at each dose level for each measurement of blood flow. Similar dose-response curves were constructed for norepinephrine bitartrate (Levophed, Winthrop), 0.3-3.0 ^g/min, i.a. a-Adrenergic blockade was induced with either phentolamine mesylate (Regitine, CIBA), 0.1-1.0 mg/min, or phenoxybenzamine hydrochloride (Dibenzyline, Smith, Kline and French), 1.0 mg/kg, infused i.a. for 10-30 minutes before VOL. 38, No. 3, MARCH 1976 assessing the renal vascular response or the adequacy of blockade. Similarly l-Sar,8-Ala-angiotensin II (PI 13, Saralasin, Norwich), 10-300 ng/kg per min, and BPF 9 a (Schwarz/Mann), 10-100 ng/kg per min, were infused i.a. for 3-5 minutes before assessing the vascular response or adequacy of blockade. Propranolol hydrochloride (Ayerst), 1.5-2.0 mg/kg, was infused intravenously 20 minutes before the determination of renal blood flow.
The highest dose of phentolamine, phenoxybenzamine, and PI 13 used was adequate to shift the dose-response relationship for the relevant agonist by more than one order of magnitude. For example, phentolamine in four dogs obliterated the response to an infusion of norepinephrine of 3.0 /ig/min (-2.2 ± 0.3 vs. +0.21 ± 0.6 ml/g per min; P < 0.01). These doses of phentolamine did not influence either the renal vascular response to angiotensin or the blood pressure. Because of limited supplies of BPF 9 a it was possible to assess its influence on responses to angiotensin I in only one dog. A dose of angiotensin I of 500 ng/min reduced renal flow from 3.2 to 1.3 ml/g per min in the absence of BPF 9 a and failed to induce a response during the infusion of BPF 9 a at 30 ng/kg per min. In this animal BPF 9 a at 100 ng/kg per min did not modify the renal vascular responses to angiotensin II or norepinephrine.
In five dogs balance was achieved on a low salt diet (Nutritional Biochemicals), as evidenced by a drop in weight of approximately 1 kg and a urine sodium concentration of less than 15 mEq/liter, or on a high salt diet which provided at least 40 g (684 mEq) of sodium chloride daily. Tap water was replaced with distilled water for the dogs on a low salt diet. The dogs in the balance study were housed in a metabolism cage which allowed 24-hour urine collection. The other dogs were allowed an intake of standard laboratory chow and tap water ad libitum; this generally provided a sodium intake of about 40 mEq/day.
Group means have been presented with the standard error of the mean as the index of dispersion. Statistical probability was evaluated, where appropriate, with Student's /-test or the paired data test, or by analysis of variance. Otherwise the Wilcoxon rank sum test (WRST) or Fisher exact test (FET) for nonparametric data was used. The null hypothesis was rejected when the P value was less than 0.05.
Results
During the first several weeks after surgery, renal blood flow in the unanesthetized dogs tended to vary from day to day. During this interval the average of 101 determinations was 3.7 ± 0.1 ml/g per min, significantly less than the average value for the same dogs when successful training had been accomplished (4.1 ± 0.1 ml/g per min; n = 91; P < 0.01). The variability is evident in the coefficient of variation which, in the early period, averaged 28 ± 3% and was significantly greater than the coefficient of variation once stability had been achieved (13 ± 1%; P < 0.005). Typical day-to-day variability for one dog after training had been accomplished is shown in Figure 1 .
The effect of induction of anesthesia, without surgery, on renal blood flow in the same dog also is shown in Figure 1 91; P < 0.001) or thiopental sodium (4.5 ± 0.4 to 3.2 ± 0.5; n = 8; P < 0.01) resulted in a striking reduction in mean renal blood flow. Mean arterial pressure in the unanesthetized dogs averaged 93.8 ± 2.0 mm Hg, and heart rate was 64.5 ± 1.4 beats/min. In dogs anesthetized with pentobarbital sodium but not exposed to surgical stress or environmental stimuli, arterial pressure was unchanged (91.8 ± 1.3 mm Hg), but there was a striking tachycardia (140 ± 2.4 beats/min). Surgical trauma induced a variable, but generally very large, increase in arterial pressure to levels which often exceeded 140 mm Hg. The reduction in mean renal blood flow was associated with a significant decrease in both the rapid component flow rate (6.4 ± 0.3 to 5.1 ± 0.4 ml/g per min; P < 0.025) and in the percentage of flow entering this compartment (82.7 ± 1.5% vs. 62.6 ± 3.6%; P < 0.001). There was a reciprocal increase in the percentage entering the second compartment Results are expressed as mean ± SEM. * The PI 13 dose was that in any study which induced the largest increase in mean renal blood flow.
(9.8 ± 1.2% to 26.0 ± 4.0%; P < 0.001). These findings are summarized in Figure 2 and Table 1 .
In Figure 3 the renal vascular responses of anesthetized dogs to a-adrenergic blockade with phenoxybenzamine or phentolamine are contrasted to the spontaneous variability of blood flow under anesthesia. Sequential flow determinations in the absence of a pharmacological agent during the 60 minutes after the induction of anesthesia revealed a random change, II of 21 second determinations exceeding the first. Neither a-blocker induced a systematic increase in blood flow under anesthesia (7 of 13 increased), despite large doses which were more than adequate to induce a highly significant degree of a-adrenergic blockade. Neither agent induced systemic hypotension when infused into the renal artery in the doses used.
The renal vascular response to anesthesia in six animals treated with very high salt intake for at least a week before induction of anesthesia is shown in Figure 4 . In contrast to the striking reduction in blood flow induced by anesthesia in animals on an unrestricted diet, renal blood flow did not fall in the dogs on a high salt intake. Renal blood flow in the unanesthetized animal averaged 4.7 ± 0.3 ml/g per min and was significantly greater than in the animals when intake was unrestricted (P < 0.025). After induction of anesthesia, flow averaged 4.9 ± 0.1 ml/g per min and was not significantly greater than the preinduction value (P < 0.20).
The influence on renal blood flow of the two classes of agents which interrupt the renin-angiotensin system in the three states is summarized in Figure 5 . In dogs which were awake and on an unrestricted intake, PI 13. induced a dose-related reduction in mean blood flow (P < 0.01). Conversely, when the same animals were anesthetized with either pentobarbital or thiopental, PI 13 induced a dose-related increase in renal blood flow (chi square = 26.5; P < 0.005). The addition of a second stimulus to activation of the renin-angiotensin system, i.e., sodium restriction, produced a small but statistically significant potentiation in the renal vascular response (FET, P = 0.033). BPF 9. did not increase renal blood flow in the unanesthetized dog on an unrestricted sodium intake, but did increase renal blood flow in the anesthetized dog (WRST, P < 0.001), and induced a more striking response in the anesthetized dog on a sodiumrestricted intake (FET, P = 0.045). Renal vascular responses in unanesthetized dogs on a low salt diet were assessed only with PI 13, because the supply of BPF 9 0 was limited. The increase in blood flow induced after PI 13 was significantly less than the response in dogs in which anesthesia was added to the regimen of sodium restriction (FET, P = 0.05). Both classes of agents increased both the percentage of flow (P < 0.01) and the flow rate in the most rapid component (P < 0.05) when mean blood flow was increased (Table 1) .
Similarly, renal blood flow under pentobarbital anesthesia was increased after administration of propranolol (3.2 ± 0.09 ml/g per min; P < 0.005), although it still was reduced with respect to the control state without anesthesia (P < 0.05).
To assess the role of changing responsiveness to the endogenous vasoconstrictor agents, norepinephrine and angiotensin, we constructed dose-response curves for both agents in animals awake and under the influence of pentobarbital anesthesia. The responses to a dose of angiotensin (10 ng/min) and norepinephrine (1,000 ng/min) which induced approximately similar reductions in blood flow in the unanesthetized state (1.54 ± 0.2 vs. 1.04 ± 05 ml/g per min; I = 0.67; P < 0.50) are shown in Figure 6 . After induction of anesthesia the response to angiotensin was significantly reduced (P < 0.01) ( Figs. 6 and 7) . Conversely, the response to norepinephrine was enhanced so that responses to doses that had been equieffective when the dogs were awake were significantly different during anesthesia (-2.8 ± 0.15 vs. -0.71 ± 0.28; t = 7.45; p < 0.001). The entire dose-response curve for angiotensin in both states is presented in Figure 7 . Anesthesia reduced the vascular response to angiotensin over the entire dose-response range (chi square = 12.6; P < 0.005). Over a wide range of flows induced by varying sodium intake and with or without anesthesia there was excellent correlation between the control mean blood flow (x), and the renal vascular response to angiotensin infused into the renal artery at 100 ng/min (y = 0.7 -0.78x; r = -0.91; P < 0.01) in 53 determinations. A relationship between resting flow and response to any given dose of norepinephrine was not established. In view of the fact that the reduction in blood flow consequent to anesthesia was associated with a potentiated response to norepinephrine, this was not surprising.
Discussion
Barbiturate anesthesia consistently reduced renal blood flow in this study; this finding confirms many reports on the effects of anesthesia. 1 '" Since arterial pressure did not fall, the increase in renal vascular resistance must have reflected active vasoconstriction. The most likely candidates as mediator of the renal vascular response were the endogenous vasoconstrictor agents, norepinephrine and angiotensin. The failure of the renal vasculature to respond to very large doses of two a-adrenergic blocking agents rules out a direct effect of norepinephrine, especially in view of the evidence in this study which implicates angiotensin as the mediator. A high salt intake, the most active means of suppressing endogenous renin and angiotensin, prevented the reduction in blood flow. Moreover, three classes of pharmacological agents which interrupt the renin-angiotensin axis increased renal blood flow. It always is possible that the response to a single agent is not related to its primary action, but rather may reflect some nonspecific influence. 26 For example, BPF 9 a may increase the circulating concentration of bradykinin, an active vasodilator. It is very unlikely, however, that a similar response to these three unrelated classes of agents is nonspecific in view of their dissimilar structures and mechanisms of action. 26 PI 13 , an analogue of angiotensin II, acts as a competitive antagonist. BPF 9 a , which is unrelated structurally, acts by blocking the conversion of angiotensin I to angiotensin II. Propranolol has an unrelated structure and acts by preventing renin release. Unfortunately it, too, has intrinsic activity and thereby reduces renal blood flow. 26 " Because PI 13 and propranolol both reduce renal blood flow directly, it is difficult to use the magnitude of the flow response to assess the magnitude of the reduction in flow mediated by angiotensin. However, it is clear that an increase in renal blood flow induced by either agent cannot be attributed to intrinsic activity, but rather must reflect their ability to interrupt the renin-angiotensin system. This study may shed light on discrepancies between earlier reports on the influence of anesthetic agents on renal blood flow. Whereas many agents reduced blood flow, 1 "" exceptions have been noted. For example, Schmid 18 found that barbiturate anesthesia did not reduce renal blood flow in the trained dog. Daily sodium excretion (Schmid, 18 Table 1 ) was 124 mEq/day, about 3 times higher than in our dogs on an unrestricted intake. A high salt intake prevents anesthesia-induced responses. Perhaps variability of salt intake accounts for the finding by some investigators that halothane 2 and chloralose-urethane 10 reduce renal blood flow where others have failed to obtain such responses. 8 
-•• "•
This investigation also may shed light on the remarkable disparity in reports on the sensitivity of the renal vasculature to angiotensin 11. In unanesthetized man on an unrestricted sodium intake the renal blood supply is sensitive to inflow concentration changes as small as 3 pg/ml. 16 -27 Sodium restriction, which activates the renin-angiotensin system, increases the threshold sensitivity more than 10-fold. In the dog much larger amounts of angiotensin II are required to reduce renal blood flow."' 22 Waugh 21 indicated that a very large change in the inflow concentration, 85 pg/ml, was in the physiological range. Other studies reported an even lower sensitivity."-19 -2 " Cannon et al. 22 and Levitin et al. 7 pointed out the potential role of anesthesia in causing the discrepant results. Conversely, Schmid 18 denied an influence of barbiturate anesthesia, not only on resting renal blood flow but on its response to angiotensin II. Again the available data on sodium excretion may resolve the dilemma. Cannon's dogs (their Table I ) were excreting 43 mEq of sodium per day, a value similar to the spontaneous intake in this study. 22 In these dogs anesthesia blunted the vascular response to angiotensin II. Schmid's animals ingested 3fold more sodium. 18 The difference between man and dog, therefore, probably reflects not species differences but rather the experimental protocols, especially sodium intake and anesthesia. The normal kidney is sufficiently sensitive to angiotensin II to respond to physiological concentrations.
The striking relationship between resting renal blood flow and its response to angiotensin II suggests that the factors which determine the two phenomena are linked. Activation of the renin-angiotensin system reduces vascular responsiveness to angiotensin II, perhaps by receptor occupancy. 16 -27 -Z8 Enhanced responsiveness to norepinephrine during anesthesia rules out a major role of arteriolar geometry. The change in vascular responsiveness to angiotensin II may have been due to activation of prostaglandin synthetase, mediated by anesthesia-induced renin release. Angiotensin increases renal prostaglandin release, and prostaglandins interfere with responsiveness to angiotensin II. 29 • 30 Moreover, prostaglandin synthetase inhibitors enhance renal vascular responses to angiotensin II." 1 so Indeed, consistent with this possibility is the finding that synthetase inhibitors have less effect on renal blood flow in the unanesthetized than the anesthetized animal. 31 32 The renin-angiotensin system is activated and renal blood flow is reduced without major surgery required to expose the kidney; this additional stimulus would be anticipated to enhance the response. 83 Virtually every study on the detailed physiology of the kidney has been performed under the influence of anesthetic agents. Certainly the interpretation of these experiments must take into account a background which includes a reduction in renal blood flow due to biologically significant activation of the renin-angiotensin system. The influence of prior sodium intake on this response not only provides an explanation for discrepancies in earlier reports, but also provides an approach to avoiding this problem. The amount of sodium required to prevent the response, however, must be defined for each species, each anesthetic regimen, and each surgical preparation.
